Liquid biopsy identifies actionable dynamic predictors of resistance to Trastuzumab Emtansine (T-DM1) in advanced HER2-positive breast cancer

Detalles Bibliográficos
Autores principales: Allegretti, Matteo, Fabi, Alessandra, Giordani, Elena, Ercolani, Cristiana, Romania, Paolo, Nisticò, Cecilia, Gasparro, Simona, Barberi, Vittoria, Ciolina, Maria, Pescarmona, Edoardo, Giannarelli, Diana, Ciliberto, Gennaro, Cognetti, Francesco, Giacomini, Patrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628389/
https://www.ncbi.nlm.nih.gov/pubmed/34839818
http://dx.doi.org/10.1186/s12943-021-01438-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628389/
https://www.ncbi.nlm.nih.gov/pubmed/34839818
http://dx.doi.org/10.1186/s12943-021-01438-z

Ejemplares similares